Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Osteoblasts | 11 | 2024 | 394 | 1.780 |
Why?
|
Bone Neoplasms | 12 | 2024 | 2668 | 1.070 |
Why?
|
Prostatic Neoplasms | 13 | 2024 | 5996 | 0.820 |
Why?
|
Cell Differentiation | 10 | 2020 | 4191 | 0.710 |
Why?
|
Tretinoin | 3 | 2012 | 621 | 0.690 |
Why?
|
Aldehyde Oxidoreductases | 3 | 2012 | 33 | 0.580 |
Why?
|
Endothelium, Vascular | 1 | 2017 | 896 | 0.420 |
Why?
|
Radium | 2 | 2021 | 97 | 0.340 |
Why?
|
Tumor Microenvironment | 4 | 2024 | 2999 | 0.310 |
Why?
|
Spinal Cord | 1 | 2012 | 724 | 0.310 |
Why?
|
Culture Media, Conditioned | 2 | 2019 | 257 | 0.310 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2019 | 347 | 0.290 |
Why?
|
Stem Cells | 3 | 2011 | 1231 | 0.280 |
Why?
|
Cadherins | 3 | 2014 | 676 | 0.270 |
Why?
|
Heart | 2 | 2010 | 1214 | 0.270 |
Why?
|
Cell Movement | 6 | 2021 | 2503 | 0.270 |
Why?
|
Neoplasm Staging | 2 | 2018 | 13989 | 0.270 |
Why?
|
Mice | 26 | 2024 | 36006 | 0.240 |
Why?
|
Nephrosclerosis | 2 | 2013 | 12 | 0.210 |
Why?
|
Mice, SCID | 5 | 2020 | 1851 | 0.210 |
Why?
|
Osteolysis | 2 | 2020 | 99 | 0.210 |
Why?
|
Bone Marrow Cells | 4 | 2011 | 981 | 0.200 |
Why?
|
Tenascin | 1 | 2021 | 56 | 0.200 |
Why?
|
Bone Marrow | 2 | 2021 | 2431 | 0.190 |
Why?
|
Fibroblasts | 3 | 2013 | 1669 | 0.190 |
Why?
|
Wnt Signaling Pathway | 1 | 2024 | 445 | 0.190 |
Why?
|
Bone Morphogenetic Protein 4 | 2 | 2021 | 103 | 0.190 |
Why?
|
Animals | 27 | 2024 | 62757 | 0.190 |
Why?
|
Endothelial Cells | 2 | 2024 | 1047 | 0.190 |
Why?
|
Carcinoma, Renal Cell | 3 | 2020 | 2417 | 0.180 |
Why?
|
Bone Morphogenetic Protein 1 | 1 | 2019 | 4 | 0.180 |
Why?
|
Prostatic Neoplasms, Castration-Resistant | 2 | 2024 | 469 | 0.180 |
Why?
|
Neoplasm Metastasis | 4 | 2021 | 5328 | 0.170 |
Why?
|
Anilides | 2 | 2020 | 296 | 0.170 |
Why?
|
Disease Progression | 3 | 2021 | 6905 | 0.170 |
Why?
|
Receptors, Interleukin-6 | 3 | 2000 | 67 | 0.170 |
Why?
|
Adiposity | 1 | 2021 | 238 | 0.170 |
Why?
|
Intercellular Signaling Peptides and Proteins | 2 | 2014 | 672 | 0.160 |
Why?
|
Signal Transduction | 7 | 2019 | 12219 | 0.160 |
Why?
|
Extracellular Vesicles | 1 | 2021 | 135 | 0.160 |
Why?
|
Bone and Bones | 3 | 2018 | 612 | 0.160 |
Why?
|
beta Catenin | 2 | 2014 | 691 | 0.160 |
Why?
|
Acetyl Coenzyme A | 1 | 2018 | 23 | 0.150 |
Why?
|
Glypicans | 1 | 2018 | 49 | 0.150 |
Why?
|
Connective Tissue Cells | 1 | 1997 | 9 | 0.150 |
Why?
|
Macrophages | 1 | 2024 | 1376 | 0.150 |
Why?
|
Dihydrotestosterone | 1 | 1997 | 116 | 0.150 |
Why?
|
Proteoglycans | 1 | 2018 | 276 | 0.140 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 184 | 0.140 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2018 | 229 | 0.140 |
Why?
|
Mice, Transgenic | 2 | 2017 | 4370 | 0.140 |
Why?
|
Cell Line, Tumor | 9 | 2024 | 14868 | 0.130 |
Why?
|
Extracellular Matrix Proteins | 1 | 2017 | 303 | 0.130 |
Why?
|
Gene Expression | 3 | 2021 | 3688 | 0.130 |
Why?
|
Tumor Cells, Cultured | 3 | 2020 | 5804 | 0.130 |
Why?
|
Radiopharmaceuticals | 1 | 2021 | 1338 | 0.130 |
Why?
|
Pyridines | 2 | 2020 | 1311 | 0.120 |
Why?
|
Ossification, Heterotopic | 1 | 2015 | 70 | 0.120 |
Why?
|
p120 GTPase Activating Protein | 1 | 2014 | 8 | 0.120 |
Why?
|
Neoplasms, Germ Cell and Embryonal | 1 | 2018 | 343 | 0.120 |
Why?
|
Kidney Neoplasms | 2 | 2020 | 3150 | 0.120 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2020 | 3924 | 0.120 |
Why?
|
Mice, Knockout | 8 | 2018 | 5838 | 0.120 |
Why?
|
Male | 19 | 2024 | 128836 | 0.120 |
Why?
|
Testicular Neoplasms | 1 | 2018 | 555 | 0.110 |
Why?
|
Estradiol | 1 | 1997 | 881 | 0.110 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2021 | 850 | 0.110 |
Why?
|
Drug Resistance, Neoplasm | 2 | 2018 | 5420 | 0.110 |
Why?
|
Adiponectin | 1 | 2013 | 164 | 0.100 |
Why?
|
Nestin | 1 | 2012 | 42 | 0.100 |
Why?
|
Transforming Growth Factor beta | 1 | 2017 | 1133 | 0.100 |
Why?
|
Intermediate Filament Proteins | 1 | 2012 | 81 | 0.100 |
Why?
|
Genes, fos | 1 | 1992 | 58 | 0.100 |
Why?
|
Up-Regulation | 1 | 2018 | 2457 | 0.100 |
Why?
|
Chemokine CXCL6 | 1 | 2011 | 17 | 0.100 |
Why?
|
Stromal Cells | 3 | 2021 | 835 | 0.100 |
Why?
|
Cell Survival | 1 | 2018 | 3075 | 0.100 |
Why?
|
Tubulin | 1 | 2012 | 203 | 0.100 |
Why?
|
Carcinogenesis | 1 | 2018 | 1037 | 0.100 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2015 | 3651 | 0.100 |
Why?
|
Receptors, CCR2 | 1 | 2011 | 45 | 0.100 |
Why?
|
Membrane Glycoproteins | 3 | 2000 | 1103 | 0.090 |
Why?
|
Ganglia, Spinal | 1 | 2012 | 255 | 0.090 |
Why?
|
Fibroblast Growth Factors | 1 | 2012 | 263 | 0.090 |
Why?
|
Neural Stem Cells | 1 | 2012 | 184 | 0.090 |
Why?
|
Antigens, CD | 3 | 2000 | 1436 | 0.090 |
Why?
|
Cystatin C | 1 | 2010 | 58 | 0.090 |
Why?
|
Angiotensin II | 1 | 2011 | 204 | 0.090 |
Why?
|
Drugs, Chinese Herbal | 1 | 2010 | 63 | 0.090 |
Why?
|
DNA-Binding Proteins | 5 | 2004 | 5067 | 0.090 |
Why?
|
Fibroblast Growth Factor 2 | 1 | 2010 | 243 | 0.080 |
Why?
|
Monocytes | 1 | 2013 | 788 | 0.080 |
Why?
|
Receptors, Notch | 1 | 2012 | 377 | 0.080 |
Why?
|
Cell Lineage | 1 | 2012 | 706 | 0.080 |
Why?
|
Transcription Factors | 4 | 2021 | 5504 | 0.080 |
Why?
|
Membrane Proteins | 2 | 2019 | 2973 | 0.080 |
Why?
|
Wnt Proteins | 1 | 2010 | 392 | 0.080 |
Why?
|
Cell Proliferation | 5 | 2020 | 7292 | 0.070 |
Why?
|
Humans | 19 | 2024 | 271636 | 0.070 |
Why?
|
Dexamethasone | 1 | 1992 | 1496 | 0.070 |
Why?
|
Myocardium | 1 | 2011 | 1251 | 0.060 |
Why?
|
Receptors, Steroid | 2 | 2004 | 356 | 0.060 |
Why?
|
Cells, Cultured | 5 | 2014 | 5779 | 0.060 |
Why?
|
Heart Diseases | 1 | 2011 | 739 | 0.060 |
Why?
|
Ganglia, Sensory | 1 | 2004 | 5 | 0.060 |
Why?
|
Kidney Diseases | 1 | 2010 | 731 | 0.060 |
Why?
|
S100 Calcium Binding Protein G | 1 | 2004 | 53 | 0.060 |
Why?
|
Tyrosine 3-Monooxygenase | 1 | 2004 | 88 | 0.060 |
Why?
|
Kidney | 1 | 2013 | 2265 | 0.060 |
Why?
|
Nerve Tissue Proteins | 1 | 2012 | 1597 | 0.060 |
Why?
|
Adaptor Proteins, Signal Transducing | 2 | 2021 | 1482 | 0.060 |
Why?
|
Neurons, Afferent | 1 | 2004 | 130 | 0.060 |
Why?
|
Transcription, Genetic | 1 | 2012 | 3416 | 0.060 |
Why?
|
Flow Cytometry | 1 | 2010 | 3077 | 0.060 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2004 | 168 | 0.060 |
Why?
|
Interleukin-6 | 2 | 1998 | 1066 | 0.060 |
Why?
|
Oligodendroglia | 1 | 2004 | 112 | 0.050 |
Why?
|
Blotting, Western | 3 | 2014 | 3646 | 0.050 |
Why?
|
Prostate | 2 | 2019 | 1138 | 0.050 |
Why?
|
Myelin Sheath | 1 | 2004 | 170 | 0.050 |
Why?
|
Fluorescent Antibody Technique | 2 | 2014 | 1142 | 0.050 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2008 | 1524 | 0.050 |
Why?
|
Cell Adhesion | 2 | 2014 | 1041 | 0.050 |
Why?
|
Ureteral Obstruction | 2 | 2013 | 162 | 0.050 |
Why?
|
Interleukin-5 | 1 | 2000 | 69 | 0.050 |
Why?
|
Real-Time Polymerase Chain Reaction | 2 | 2014 | 1212 | 0.040 |
Why?
|
Antibodies, Monoclonal | 1 | 2013 | 4495 | 0.040 |
Why?
|
Phenotype | 1 | 2012 | 6510 | 0.040 |
Why?
|
Electroporation | 1 | 2021 | 127 | 0.040 |
Why?
|
Immunohistochemistry | 4 | 2015 | 7817 | 0.040 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2021 | 9093 | 0.040 |
Why?
|
Osteoclasts | 1 | 2000 | 158 | 0.040 |
Why?
|
Cellular Reprogramming | 1 | 2021 | 202 | 0.040 |
Why?
|
Leptin | 1 | 2021 | 312 | 0.040 |
Why?
|
Adipocytes | 1 | 2021 | 308 | 0.040 |
Why?
|
Prognosis | 1 | 2017 | 22525 | 0.040 |
Why?
|
Mutation | 3 | 2018 | 15913 | 0.040 |
Why?
|
Fibrosis | 2 | 2013 | 746 | 0.040 |
Why?
|
Calcitriol | 1 | 1999 | 146 | 0.040 |
Why?
|
Choriocarcinoma, Non-gestational | 1 | 2018 | 6 | 0.040 |
Why?
|
Parathyroid Hormone | 1 | 1999 | 198 | 0.040 |
Why?
|
Carnitine O-Acetyltransferase | 1 | 2018 | 5 | 0.040 |
Why?
|
Mice, Inbred C57BL | 4 | 2013 | 7222 | 0.040 |
Why?
|
Coculture Techniques | 1 | 2020 | 631 | 0.040 |
Why?
|
Acyl-CoA Oxidase | 1 | 2018 | 13 | 0.040 |
Why?
|
Endodermal Sinus Tumor | 1 | 2018 | 50 | 0.040 |
Why?
|
Exosomes | 1 | 2021 | 253 | 0.040 |
Why?
|
Biomarkers, Tumor | 1 | 2017 | 10743 | 0.040 |
Why?
|
Interleukin-1 | 1 | 1999 | 477 | 0.040 |
Why?
|
A549 Cells | 1 | 2018 | 128 | 0.040 |
Why?
|
Autopsy | 1 | 2018 | 178 | 0.040 |
Why?
|
Skull | 1 | 2019 | 252 | 0.040 |
Why?
|
Oxidoreductases | 1 | 2018 | 168 | 0.040 |
Why?
|
In Vitro Techniques | 1 | 2020 | 1742 | 0.040 |
Why?
|
X-Ray Microtomography | 1 | 2017 | 138 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 641 | 0.040 |
Why?
|
Gene Knockout Techniques | 1 | 2017 | 272 | 0.030 |
Why?
|
Mesoderm | 1 | 1998 | 397 | 0.030 |
Why?
|
Trans-Activators | 2 | 2000 | 1660 | 0.030 |
Why?
|
Ovariectomy | 1 | 1997 | 372 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2017 | 7463 | 0.030 |
Why?
|
Oxidation-Reduction | 1 | 2018 | 718 | 0.030 |
Why?
|
RNA | 1 | 2021 | 1069 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2021 | 1294 | 0.030 |
Why?
|
Cytokine Receptor gp130 | 3 | 2000 | 26 | 0.030 |
Why?
|
Receptors, Androgen | 1 | 2021 | 909 | 0.030 |
Why?
|
Heterografts | 1 | 2017 | 745 | 0.030 |
Why?
|
Mass Spectrometry | 1 | 2017 | 726 | 0.030 |
Why?
|
Fatty Acids | 1 | 2018 | 448 | 0.030 |
Why?
|
Prostatectomy | 1 | 2019 | 1006 | 0.030 |
Why?
|
CRISPR-Cas Systems | 1 | 2018 | 353 | 0.030 |
Why?
|
In Situ Hybridization | 2 | 2008 | 1062 | 0.030 |
Why?
|
Binding Sites, Antibody | 1 | 2013 | 128 | 0.030 |
Why?
|
Immunoprecipitation | 1 | 2014 | 593 | 0.030 |
Why?
|
Mice, Nude | 1 | 2021 | 4358 | 0.030 |
Why?
|
COUP Transcription Factors | 2 | 2004 | 46 | 0.030 |
Why?
|
Epitope Mapping | 1 | 2013 | 110 | 0.030 |
Why?
|
RNA, Messenger | 2 | 2014 | 6488 | 0.030 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2014 | 1093 | 0.030 |
Why?
|
Immunoenzyme Techniques | 1 | 2014 | 1209 | 0.030 |
Why?
|
Oncogene Proteins v-fos | 1 | 1992 | 3 | 0.030 |
Why?
|
NF-kappa B | 1 | 1999 | 1568 | 0.030 |
Why?
|
Protein Isoforms | 1 | 2014 | 860 | 0.030 |
Why?
|
Th2 Cells | 1 | 2013 | 253 | 0.030 |
Why?
|
Reperfusion Injury | 1 | 2013 | 155 | 0.030 |
Why?
|
Cycloheximide | 1 | 1992 | 111 | 0.030 |
Why?
|
Receptors, CXCR4 | 1 | 2014 | 278 | 0.020 |
Why?
|
Chemokine CXCL16 | 1 | 2011 | 12 | 0.020 |
Why?
|
Receptors, CXCR6 | 1 | 2011 | 16 | 0.020 |
Why?
|
Receptors, CXCR | 1 | 2011 | 18 | 0.020 |
Why?
|
Microfilament Proteins | 1 | 2014 | 497 | 0.020 |
Why?
|
Precipitin Tests | 1 | 1992 | 359 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2014 | 1085 | 0.020 |
Why?
|
Myofibroblasts | 1 | 2011 | 103 | 0.020 |
Why?
|
Cisplatin | 1 | 2018 | 2497 | 0.020 |
Why?
|
Blood Urea Nitrogen | 1 | 2010 | 100 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2014 | 1468 | 0.020 |
Why?
|
Cardiomegaly | 1 | 2011 | 181 | 0.020 |
Why?
|
AMP-Activated Protein Kinases | 1 | 2013 | 408 | 0.020 |
Why?
|
Ventricular Remodeling | 1 | 2011 | 192 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 5180 | 0.020 |
Why?
|
Stroke Volume | 1 | 2011 | 578 | 0.020 |
Why?
|
Lymphatic Metastasis | 1 | 2018 | 4967 | 0.020 |
Why?
|
Amino Acid Sequence | 1 | 2014 | 4635 | 0.020 |
Why?
|
Creatinine | 1 | 2010 | 546 | 0.020 |
Why?
|
Heart Rate | 1 | 2011 | 760 | 0.020 |
Why?
|
Ventricular Dysfunction, Left | 1 | 2011 | 414 | 0.020 |
Why?
|
Protein Biosynthesis | 1 | 1992 | 1035 | 0.020 |
Why?
|
Survival Rate | 1 | 2021 | 12530 | 0.020 |
Why?
|
Ventricular Function, Left | 1 | 2011 | 580 | 0.020 |
Why?
|
Molecular Sequence Data | 1 | 2014 | 6781 | 0.020 |
Why?
|
Glomerular Filtration Rate | 1 | 2010 | 603 | 0.020 |
Why?
|
Analysis of Variance | 1 | 2011 | 2334 | 0.020 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2008 | 249 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 1997 | 4193 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3363 | 0.020 |
Why?
|
Apoptosis | 1 | 2020 | 7834 | 0.020 |
Why?
|
Blood Pressure | 1 | 2011 | 1595 | 0.020 |
Why?
|
Chronic Disease | 1 | 2010 | 1849 | 0.020 |
Why?
|
Gene Dosage | 1 | 2008 | 829 | 0.020 |
Why?
|
Calbindins | 1 | 2004 | 21 | 0.020 |
Why?
|
Octamer Transcription Factor-6 | 1 | 2004 | 4 | 0.010 |
Why?
|
Ultrasonography | 1 | 2011 | 1935 | 0.010 |
Why?
|
Cytokines | 1 | 2013 | 2837 | 0.010 |
Why?
|
Vagus Nerve | 1 | 2004 | 70 | 0.010 |
Why?
|
Tongue | 1 | 2004 | 85 | 0.010 |
Why?
|
COUP Transcription Factor I | 1 | 2004 | 95 | 0.010 |
Why?
|
Sciatic Nerve | 1 | 2004 | 123 | 0.010 |
Why?
|
Nerve Fibers, Myelinated | 1 | 2004 | 121 | 0.010 |
Why?
|
Chickens | 1 | 2004 | 791 | 0.010 |
Why?
|
STAT3 Transcription Factor | 2 | 2000 | 1146 | 0.010 |
Why?
|
Optic Nerve | 1 | 2004 | 139 | 0.010 |
Why?
|
Tissue Distribution | 1 | 2004 | 946 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2021 | 10354 | 0.010 |
Why?
|
Nuclear Receptor Subfamily 6, Group A, Member 1 | 1 | 2001 | 13 | 0.010 |
Why?
|
Genes, Reporter | 1 | 2004 | 832 | 0.010 |
Why?
|
Hypertension | 1 | 2011 | 1617 | 0.010 |
Why?
|
Oncostatin M | 1 | 2000 | 22 | 0.010 |
Why?
|
3T3 Cells | 1 | 2000 | 387 | 0.010 |
Why?
|
Mutagenesis | 1 | 2001 | 524 | 0.010 |
Why?
|
Receptor Activator of Nuclear Factor-kappa B | 1 | 1999 | 45 | 0.010 |
Why?
|
Biomarkers | 1 | 2011 | 5111 | 0.010 |
Why?
|
Interleukin-11 | 1 | 1998 | 38 | 0.010 |
Why?
|
RANK Ligand | 1 | 1999 | 116 | 0.010 |
Why?
|
Down-Regulation | 1 | 2004 | 2105 | 0.010 |
Why?
|
Middle Aged | 2 | 2018 | 90349 | 0.010 |
Why?
|
Time Factors | 1 | 2011 | 13116 | 0.010 |
Why?
|
Ligands | 1 | 1999 | 1057 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2004 | 3262 | 0.010 |
Why?
|
Enzyme Activation | 1 | 1999 | 1832 | 0.010 |
Why?
|
Follow-Up Studies | 1 | 2010 | 15254 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2018 | 39731 | 0.010 |
Why?
|
Peptides | 1 | 2000 | 1528 | 0.010 |
Why?
|
Transfection | 1 | 1999 | 3165 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2001 | 1730 | 0.010 |
Why?
|
Female | 2 | 2010 | 148992 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2015 | 14653 | 0.010 |
Why?
|
Cell Line | 1 | 2000 | 5431 | 0.010 |
Why?
|
Adult | 1 | 2018 | 81791 | 0.010 |
Why?
|
Carrier Proteins | 1 | 1999 | 2138 | 0.010 |
Why?
|
Brain | 1 | 2004 | 4251 | 0.010 |
Why?
|